Amgen, Inc. (AMGN)
374.75
-0.75
(-0.20%)
USD |
NASDAQ |
Feb 20, 16:00
375.49
+0.74
(+0.20%)
After-Hours: 20:00
Amgen SG&A Expense (Quarterly) : 1.952B for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.794B |
| Johnson & Johnson | 6.753B |
| Eli Lilly & Co. | 3.132B |
| Merck & Co., Inc. | 2.898B |
| Regeneron Pharmaceuticals, Inc. | 775.00M |